Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-18 Purchase |
2021-08-19 4:24 pm |
PhaseBio Pharmaceuticals Inc | PHAS | Hutson Nancy J Director |
3,000 | $3.08 | $9,240 | 4,000 (Indirect) |
View |
| 2021-08-18 Purchase |
2021-08-18 6:07 pm |
PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director |
10,000 | $3 | $30,000 | 32,943 (Direct) |
View |
| 2021-05-20 Sale |
2021-05-24 6:11 pm |
PhaseBio Pharmaceuticals Inc | PHAS | Burkhardt Glen VP, Human Resources |
3,811 | $3.29 | $12,538 | 0 (Direct) |
View |
| 2020-12-03 Purchase |
2020-12-04 3:53 pm |
PhaseBio Pharmaceuticals Inc | PHAS | HARRIGAN EDMUND Director |
6,000 | $4.12 | $24,720 | 6,000 (Direct) |
View |
| 2020-11-23 Purchase |
2020-11-24 4:04 pm |
PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director |
5,000 | $3.602 | $18,010 | 22,943 (Direct) |
View |
| 2020-11-23 Sale |
2020-11-23 6:27 pm |
PhaseBio Pharmaceuticals Inc | PHAS | Burkhardt Glen VP, Human Resources |
3,497 | $3.45 | $12,065 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-14 Option Award |
2021-09-15 08:15 am |
N/A 2031-09-14 |
PhaseBio Pharmaceuticals Inc | PHAS | Humphries William D. Director |
28,000 | $0 | 28,000 (Direct) |
View |
| 2021-07-12 Exercise(A) |
2021-09-03 4:43 pm |
2015-07-12 2021-07-12 |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth VP, Preclinical and Chem |
4,519 | $0 | 27,760 (Direct) |
View |
| 2021-07-12 Exercise(A) |
2021-09-03 4:43 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth VP, Preclinical and Chem |
4,519 | $1.74 | 27,760 (Direct) |
View |
| 2021-08-03 Exercise(A) |
2021-09-03 4:41 pm |
2020-04-11 2026-05-12 |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
7,500 | $0 | 148,306 (Direct) |
View |
| 2021-08-03 Exercise(A) |
2021-09-03 4:41 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
7,500 | $1.68 | 148,306 (Direct) |
View |
| 2021-08-27 Exercise |
2021-08-30 5:52 pm |
2018-10-08 2024-11-04 |
PhaseBio Pharmaceuticals Inc | PHAS | Mow Jonathan P Chief Executive Officer |
20,000 | $0 | 275,617 (Direct) |
View |
| 2021-08-27 Exercise |
2021-08-30 5:52 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Mow Jonathan P Chief Executive Officer |
20,000 | $1.24 | 275,617 (Direct) |
View |
| 2021-08-03 Option Award |
2021-08-04 6:58 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
7,500 | $1.68 | 50,224 (Direct) |
View |
| 2021-07-12 Option Award |
2021-07-14 7:06 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth VP, Preclinical and Chem |
4,519 | $1.74 | 27,760 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 6:17 pm |
N/A 2031-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | van den Broek Richard Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 6:14 pm |
N/A 2031-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Sapir Alex Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 6:08 pm |
N/A 2031-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | HARRIGAN EDMUND Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 6:07 pm |
N/A 2031-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Klein Peter Justin Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 6:06 pm |
N/A 2031-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Loewy Caroline M Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 6:05 pm |
N/A 2031-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Hutson Nancy J Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 6:03 pm |
N/A 2031-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 6:11 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
1,419 | $2.8 | 42,724 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 6:11 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Burkhardt Glen VP, Human Resources |
3,811 | $2.8 | 0 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 6:10 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Mow Jonathan P Chief Executive Officer |
3,964 | $2.8 | 126,850 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 6:10 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | York Michael VP, Corporate Development |
2,897 | $2.8 | 7,059 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 6:09 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth VP, Preclinical and Chem |
5,257 | $2.8 | 23,241 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 6:09 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Hanson Kristopher VP, Head of Legal |
1,088 | $2.8 | 2,087 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 4:56 pm |
N/A 2031-02-05 |
PhaseBio Pharmaceuticals Inc | PHAS | Mow Jonathan P Chief Executive Officer |
234,000 | $0 | 234,000 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 4:54 pm |
N/A 2031-02-05 |
PhaseBio Pharmaceuticals Inc | PHAS | Hanson Kristopher VP, Head of Legal |
36,000 | $0 | 36,000 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 4:52 pm |
N/A 2031-02-05 |
PhaseBio Pharmaceuticals Inc | PHAS | York Michael VP, Corporate Development |
36,000 | $0 | 36,000 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 4:50 pm |
N/A 2031-02-05 |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth VP, Preclinical and Chem |
36,000 | $0 | 36,000 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 4:48 pm |
N/A 2031-02-05 |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
76,500 | $0 | 76,500 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 4:45 pm |
N/A 2031-02-05 |
PhaseBio Pharmaceuticals Inc | PHAS | Lee John Sang Chief Medical Officer |
76,500 | $0 | 76,500 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 4:40 pm |
N/A 2031-02-05 |
PhaseBio Pharmaceuticals Inc | PHAS | Burkhardt Glen VP, Human Resources |
36,000 | $0 | 36,000 (Direct) |
View |
| 2020-11-20 Option Award |
2020-11-23 6:43 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Sharp John P Chief Financial Officer |
1,305 | $3 | 41,305 (Direct) |
View |
| 2020-11-20 Option Award |
2020-11-23 6:42 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Hanson Kristopher VP, Head of Legal |
999 | $3 | 999 (Direct) |
View |
| 2020-11-20 Option Award |
2020-11-23 6:40 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | York Michael VP, Corporate Development |
2,662 | $3 | 4,162 (Direct) |
View |
| 2020-11-20 Option Award |
2020-11-23 6:38 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Ballance David James VP, Research and Sci. Affairs |
919 | $3 | 8,519 (Direct) |
View |
| 2020-11-20 Option Award |
2020-11-23 6:36 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth VP, Preclinical and Chem |
4,832 | $3 | 17,984 (Direct) |
View |
| 2020-11-20 Option Award |
2020-11-23 6:34 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Mow Jonathan P Chief Executive Officer |
3,643 | $3 | 122,886 (Direct) |
View |
| 2020-11-20 Option Award |
2020-11-23 6:27 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Burkhardt Glen VP, Human Resources |
3,497 | $3 | 0 (Direct) |
View |
| 2020-11-16 Other |
2020-11-18 7:19 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director |
65,127 | $0 | 2,495,989 (Indirect) |
View |
| 2020-08-21 Exercise |
2020-08-24 7:04 pm |
2018-10-08 2024-11-04 |
PhaseBio Pharmaceuticals Inc | PHAS | Mow Jonathan P Chief Executive Officer |
10,000 | $0 | 268,010 (Direct) |
View |
| 2020-08-21 Exercise |
2020-08-24 7:04 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Mow Jonathan P Chief Executive Officer |
10,000 | $1.24 | 268,010 (Direct) |
View |